ArticleFrontiers in endocrinology2025
Preoperative assessment for the risk of Clavien-Dindo classification ≥ II grade complications after total parathyroidectomy without auto-transplantation in patients with secondary hyperparathyroidism.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Complications following total parathyroidectomy (TPTX) without autotransplantation adversely affect the prognosis of patients with secondary hyperparathyroidism (SHPT). This study aimed to identify preoperative risk factors of Clavien-Dindo grade ≥ II complications after TPTX in SHPT patients, and develop a visualized model to predict the risk of complications (≥ grade II). Methods: Clinical data were retrospectively collected from SHPT patients who underwent TPTX at our center between January 2013 and March 2025. The cohort was chronologically divided into a training set (n=552) and a validation set (n=236) in a 7:3 ratio. Postoperative complication severity was assessed using the Clavien-Dindo classification system. Patients were stratified into two groups based on complication grade: a high-risk group (grade ≥II) and a low-risk group (grade <II or no complications). Independent risk factors of Clavien-Dindo grade ≥ II complications were identified through univariate and multivariate logistic regression analyses. A nomogram was developed using these independent risk factors. The performance of this model was then evaluated using the validation set. Results: Among 788 patients, 546 (69.3%) developed postoperative complications, including 369 cases (46.8%) of grade ≥ II complications. Multivariate analysis identified serum alkaline phosphatase, intact parathyroid hormone, serum calcium, and serum potassium as independent risk factors of grade ≥II complications. The nomogram achieved good concordance indexes of 0.826 (95% confidence interval (CI), 0.778-0.874) and 0.807 (95% confidence interval (CI), 0.739-0.874) in predicting the risk of postoperative complications (grade ≥ II) in the training and validation cohorts, respectively, with well-fitted calibration curves. Both the decision curve and the clinical impact curve indicated substantial clinical benefit provided by the nomogram. Conclusion: A nomogram was developed and validated to predict complications (grade ≥ II) following TPTX without autotransplantation in patients with SHPT. This model may aid in identifying high-risk patients and informing perioperative decision-making.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.